OGDEN CHRISTOPHER (See Remarks) sold 0.5% of their position (1.62K shares) of CYTOMX THERAPEUTICS, INC. on the open market
Open‑market sale worth $5.0K — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 6/17/2026ACC: 0001610717-26-000229
Officer· See Remarks
Since Feb 2022
-1.62K
Net shares
Net seller
$5.0K
Total sold
1
Open market trades
0B · 1S
1
Total transactions
1.62K disposed
Non-Derivative Transactions1
Common Stock
Direct
Shares
−1.62K
Price / share
$3.05
Trade value
$4.95K
% of position
0.5%
6/15/2026
296.95K→295.32K
Total
Net shares
−1.62K
Net value
-$4.95K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 6/15/2026 | S · Sale | −1.62K | $3.05 | $4.95K | 0.5% | 296.95K | 295.32K |
| Total | −1.62K | -$4.95K | ||||||
Derivative Transactions0
No derivative transactions reported